# Alpha-9 Oncology

**Canonical:** https://apis.io/providers/alpha-9-oncology/  
**Website:** https://www.a9oncology.com/  
**APIs profiled:** 0

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that spun out of the University of British Columbia and BC Cancer in 2019 to develop a portfolio of targeted cancer therapies. Alpha-9 engineers bespoke radiopharmaceutical molecules — optimizing the binder, linker, chelator, and radioisotope — to deliver radiation directly to tumor cells while limiting exposure to healthy tissue. The company operates purpose-built research facilities in Vancouver, BC and Boston, MA, and in October 2024 raised an oversubscribed $175M Series C led by Lightspeed Venture Partners and Ascenta Capital to advance its clinical pipeline. Alpha-9 is a drug developer and does not currently publish a public developer API; this profile captures its company identity and public-web surface for the API Evangelist network.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Alpha 9 Oncology Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Healthcare, Oncology, Radiopharmaceuticals, Biotechnology, Cancer Therapy, Clinical Stage, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/alpha-9-oncology/). Scores are computed from the provider's own public artifacts under a published rubric.